Get started
Author

Miguel Proença

Observed name: M. Proença
ORCID: 0000-0002-5526-7533
Observed ORCID: 0000-0002-5526-7533
OpenAlex ID: A5006860059
Nonirritant concentrations for skin testing with SARS-CoV-2 mRNA vaccine
2021 · João Marcelino, Sofia Farinha, et al. · The Journal of Allergy and Clinical Immunology In Practice · 26
PDF
Skin testing with Pfizer SARS-CoV-2 vaccine and PEG 2000
2021 · João Vieira, João Marcelino, et al. · Asia Pacific Allergy · 11
Predictors of treatment control in severe chronic urticaria treated with omalizumab
2025 · Miguel Proença, João Marcelino, et al. · Asia Pacific Allergy · 5
Successful dupilumab dose spacing in controlled severe atopic dermatitis and predictive factors
2025 · J. Vieira, J. Marcelino, et al. · European Annals of Allergy and Clinical Immunology · 3
PDF
Cold urticaria patients can be susceptible to anaphylaxis during diagnostic cold provocation tests
2025 · Miguel Proença, João Marcelino, et al. · BMJ Case Reports · 1
Hereditary alpha-tryptasemia: A case series including omalizumab treatment outcomes
2026 · Joana Guimarães, João Marcelino, et al. · Asia Pacific Allergy
Provas de provocação ocular na imunoterapia específica a alergénios – Melhoram a adesão ao tratamento?
2025 · Miguel Proença, Carlota Dias, et al. · Revista Portuguesa de Imunoalergologia
PDF
A exceção confirma a regra – Um caso clínico de alergia ao frango
2025 · Miguel Proença, Fátima Ferreira, et al. · Revista Portuguesa de Imunoalergologia
PDF
Tattoo-induced immunologic reaction to red inks
2024 · João Vieira, João Marcelino, et al. · Asia Pacific Allergy
Works count: 9
Citation count: 46
H-index: 3
I10-index: 2
Year
Topic
Type